| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 0 | ||||
| Sells | 6 | -5.84M | 100% | $12.47 | -$72.9M |
| Net | -6 | -5.84M | -100% | -$72.9M |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Skorpios Trust | 10%+ Owner | $125M | -$69M | -35.5% | Sep 19, 2024 |
| Edward M. MD Kaye | CEO, Director | $2.09M | -$722K | -25.7% | May 20, 2024 |
| Stephen Tulipano | Former CFO | $758K | -$25.1K | -3.21% | Mar 27, 2024 |
| Barry Ticho | Chief Medical Officer | $663K | -$1.28M | -65.9% | Nov 1, 2024 |
| Huw M. Nash | Chief Business Officer | $631K | -$1.64M | -72.2% | Jul 2, 2024 |
| Jonathan Allan | General Counsel & Corp Sec | $418K | -$211K | -33.6% | May 20, 2024 |
| Arthur Tzianabos | Director | $69.5K | Jun 5, 2024 | ||
| Seth Loring Harrison | Director | Jun 5, 2024 | |||
| E. Garry Menzel | Director | Jun 5, 2024 | |||
| Jennifer Burstein | Director | Jun 5, 2024 | |||
| Ian F. Smith | Director | Jun 5, 2024 | |||
| Julie Smith | Director | Jun 5, 2024 | |||
| Thomas Leggett | Chief Financial Officer | May 15, 2024 | |||
| Adrian R. Krainer | Director | Jun 5, 2024 | |||
| Arthur A. Levin | Director | Jun 5, 2024 | |||
| ATP Life Science Ventures, L.P. | 10%+ Owner | Jun 28, 2021 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|